NCT00504673已完成3 期
Comparison of the Effect of Insulin Detemir Versus Insulin NPH Both With Insulin Aspart on Weight Change in Overweight and Obese Subjects With Type 2 Diabetes
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 277
- 试验地点
- 1
- 主要终点
- Body weight loss
研究概览
简要总结
This trial is conducted in Europe. The purpose of the trial is to investigate the effect of insulin detemir on weight change in overweight and obese patients with type 2 diabetes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •HbA1c: 7.5-11.0%
- •BMI: 25-40 kg/m2
排除标准
- •Treatment with any OAD (Oral Antidiabetic Drugs) except metformin
结局指标
主要结局
Body weight loss
时间窗: after 26 weeks of treatment
次要结局
- HbA1c
- Incidence of hypoglycaemia
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Efficacy and Safety of Insulin Detemir in Type 1 DiabetesDiabetesDiabetes Mellitus, Type 1NCT00595374Novo Nordisk A/S114
终止
4 期
Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00506662Novo Nordisk A/S86
已完成
3 期
The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00856986Novo Nordisk A/S987
已完成
3 期
Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 DiabetesDiabetesDiabetes Mellitus, Type 1NCT00184639Novo Nordisk A/S71
已完成
3 期
Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00104182Novo Nordisk A/S503